ARCHITECT CYCLOSPORINE 01L75-25

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-05-23 for ARCHITECT CYCLOSPORINE 01L75-25 manufactured by Abbott Laboratories.

Event Text Entries

[45811707] An evaluation is in process. A follow-up report will be submitted when the evaluation is complete. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[45811708] The customer reports that one patient's architect cyclosporine assay result of 717ng/ml (sid (b)(4)) was questioned by a staff nurse as the previous result for this patient was 307 ng/ml. The sample was retested the following day and generated a result of 237 ng/ml. A new sample was drawn (sid (b)(4)) and generated a result of 42 ng/ml. The customer commented that the staff nurse felt this result was too low. Controls have remained within specifications. There is no reported adverse impact to patient care due to this issue. Upon troubleshooting it was discovered that the precipitation solution the customer was using (list 01l75-55, lot 524888) had expired (30 march 2016). Css advised the customer to open a new in date bottle of solution and retest all samples. Upon retest of the samples using in date precipitation solution, results were similar to those generated with the expired precipitation solution (units of measure = ng/ml): 47. 17 (expired) retest 56. 80 (in-date); 230. 96 (expired) retest 234. 62 (in-date); 237. 28 (expired) retest 239. 89 (in-date). There is no reported impact to patient care due to this issue.
Patient Sequence No: 1, Text Type: D, B5


[47816949] Accuracy testing was performed using an in-house retained reagent pack of architect cyclosporine assay lot 50160m500 (no returns were made available from the customer site). All results met specifications indicating acceptable performance of this reagent lot. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. The architect cyclosporine assay package insert contains information to address the current customer issue. Based on the available information from the customer site and from the results of this evaluation, there is no evidence to reasonably suggest a product malfunction occurred. The issue involves one discreet patient sample and retesting resulted in a lower result indicating a possible sample integrity issue. Additionally, the result was obtained with expired precipitation reagent. Section corrected to ln: (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2016-00059
MDR Report Key5673838
Date Received2016-05-23
Date of Report2016-06-09
Date of Event2016-05-02
Date Mfgr Received2016-06-09
Device Manufacturer Date2016-01-01
Date Added to Maude2016-05-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 600643500
Manufacturer CountryUS
Manufacturer Postal Code600643500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT CYCLOSPORINE
Generic NameCYCLOSPORINE
Product CodeMKW
Date Received2016-05-23
Catalog Number01L75-25
Lot Number50160M500
Device Expiration Date2016-11-11
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 600643500 US 600643500


Patients

Patient NumberTreatmentOutcomeDate
10 2016-05-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.